Quick Information
- Category:
- Healthcare
- Pricing:
- Contact Sales
- Platforms:
- Web, Cloud, PACS integration
- Free Plan:
- No
- Last Verified:
- October 2026
What Is Lunit?
Lunit is a medical AI company focused on cancer diagnostics and imaging. Its best-known products are Lunit INSIGHT MMG for mammography and Lunit INSIGHT CXR for chest X-rays. The FDA cleared INSIGHT MMG in November 2021 for breast cancer detection. It shows lesion locations and an abnormality score reflecting the AI's confidence, and it was trained on more than 240,000 mammography cases. The chest X-ray triage tool is designed to flag pleural effusion and pneumothorax.
The newest version of the mammography algorithm, 1.2, has received FDA clearance and combines AI scores with Volpara Scorecard volumetric breast density measures, adds current and prior comparison and offers three selectable thresholds. Lunit also unveiled Lunit INSIGHT Risk, a one-to-five-year breast cancer risk predictor built with Volpara, and said it planned to seek FDA approval, though clearance was not confirmed in the sources found. A chest X-ray report generation system was only a prototype in 2024 coverage. Lunit does not publish prices, so buyers need to ask the company for a quote.
Lunit fits breast imaging centres and radiology groups that want a second reader for screening mammograms. Related imaging tools include Aidoc, Qure.ai and Paige. See more in the Healthcare tools directory.
What Can You Use Lunit For?
Mammography screening
Highlights suspicious lesions and gives an abnormality score.
Chest X-ray triage
Flags pleural effusion and pneumothorax.
Breast density and risk
Works with Volpara measures for density and risk estimates.
Lunit Features
- INSIGHT MMG — FDA-cleared breast cancer detection support trained on 240,000+ cases.
- INSIGHT CXR Triage — Flags urgent chest X-ray findings.
- Volpara integration — Version 1.2 pairs AI scores with volumetric breast density.
- Prior comparison — Compares current and prior exams with selectable thresholds.
Who Is Lunit For?
- Breast imaging centres — Use AI as a second reader for screening.
- Hospital radiology teams — Triage chest X-rays for urgent findings.
Lunit Pros & Limitations
What We Like
- FDA-cleared mammography AI
- Trained on a large mammography dataset
- Integration with Volpara density measures
- Covers both breast and chest imaging
Limitations
- No public pricing
- Risk prediction product's clearance status was not confirmed
- Report generation was only a prototype in 2024 coverage
Lunit Pricing
| Plan | Price | Main Features |
|---|---|---|
| Enterprise | Custom | INSIGHT MMG, INSIGHT CXR and related products |
Pricing was last verified October 2026. Check the official website for the latest pricing.
AI Listing Jungle Ranking
- Global Rank:
- #102
- Overall Score:
- 82.5/100
- Monthly Users:
- –
- Rank Change:
- ▼ 25
This ranking reflects AI Listing Jungle's own independent scoring methodology and is not an endorsement by Lunit or its company. How Our Rankings Work
Frequently Asked Questions
Is Lunit FDA cleared?
Lunit INSIGHT MMG was cleared in November 2021, and version 1.2 has since been cleared. Check the FDA database for the full list.
What does INSIGHT CXR do?
It flags suspected pleural effusion and pneumothorax on chest X-rays.
How does Lunit use Volpara?
Version 1.2 combines AI scores with Volpara Scorecard breast density.
How much does Lunit cost?
Pricing is not published.
Our Take
Lunit has a solid regulatory track record in mammography, and the Volpara link makes the product more useful for screening programs.
Confirm clearance status for each product and version you plan to buy.
Lunit Alternatives
Lunit Comparisons
Ready to try Lunit?
Visit the official website to get started.
Visit Official WebsiteAI Listing Jungle is an independent AI tools directory. Product names, logos, and trademarks belong to their respective owners.